AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Researchers Identify Gene Linked To High Bone Mass.(Brief Article)

Women's Health Weekly

| November 15, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 NOV 15 - (NewsRx.com & NewsRx.net) -- Building on a proven program of gene discovery, scientists at Genome Therapeutics and Creighton University, Omaha, Nebraska, discovered a novel gene responsible for high bone density.

Osteoporosis, an increasingly prevalent human disease, is characterized by low bone density and structural deterioration of bone tissue. Researchers described the identification of the protein responsible for above average bone mineral density in presentations at the annual meetings of the American Society of Human Genetics (ASHG) and the American Society for Bone and Mineral Research (ASBMR) October 15, 2001.

This gene discovery is the foundation of a multiyear alliance between Genome Therapeutics and Wyeth-Ayerst for genomics-based osteoporosis drug discovery and is expected to be a promising research pathway to novel products for the prevention or treatment of osteoporosis.

Using members of a large extended family, some of whom displayed the high bone mass (HBM) trait, scientists at Creighton and Genome Therapeutics were able to identify a single amino acid change in a protein receptor responsible for above average bone mineral density. Genome Therapeutics used DNA sequencing to identify polymorphisms (specific DNA base pair changes) in the HBM candidate genes. Researchers then determined which of these polymorphisms accompanied the HBM trait. One specific variation was found exclusively in affected individuals from the extended HBM family, but not in the general population.

"Our ability to move from identifying individuals with high bone mass to isolating the genetic change responsible for this trait is a testament to the utility of positional cloning in the quest to understand human diseases," said Robert R. Recker, MD, director of the Creighton Osteoporosis Research Center. "The combination of Creighton's expertise in hereditary analysis, led by Dr. Mark Johnson, and Genome Therapeutics' command of gene identification technologies ...

Related articles from newspapers, magazines, journals, and more
RESEARCHERS FROM GENOME THERAPEUTICS AND CREIGHTON UNIVERSITY IDENTIFY GENE...
Press release article from: PR Newswire October 15, 2001 700+ words
...the high bone mass (HBM) trait...Creighton and Genome Therapeutics were able...with high bone mass, and we...process." Genome Therapeutics and Creighton...increase in bone mass. Background on the Genome Therapeutics / Wyeth...
Researchers from Genome Therapeutics and Creighton University Identify Gene...
Press release article from: PR Newswire October 15, 2001 700+ words
...the high bone mass (HBM) trait...Creighton and Genome Therapeutics were able...with high bone mass, and we...process." Genome Therapeutics and Creighton...increase in bone mass. Background on the Genome Therapeutics / Wyeth...
GenomeVision(TM) Services, a Unit of Genome Therapeutics, Receives Federal...
Press release article from: PR Newswire October 8, 2002 700+ words
...additional analysis. Genome Therapeutics retains all rights...Services leverages Genome Therapeutics' industrial-scale...genetics of asthma, high bone mass and infectious disease. About Genome Therapeutics Genome Therapeutics...
Genome Therapeutics Receives Milestone Payment from Wyeth-Ayerst for...
Press release article from: PR Newswire June 18, 2001 700+ words
...Ayerst and Genome Therapeutics, building...Research Center. Genome Therapeutics gained access...exhibiting a high bone mass trait from...alliance with Genome Therapeutics." Osteoporosis...characterized by low bone mass, structural...
Genome Therapeutics and Creighton University Publish Details of Potential New...
Press release article from: PR Newswire December 20, 2001 700+ words
...Creighton and Genome Therapeutics identified members...the high bone mass (HBM) trait...therapies that build bone mass to treat or prevent...further affirms Genome Therapeutics' leadership...In the paper, Genome Therapeutics and Creighton...leads to high ...
GENOME THERAPEUTICS.
Magazine article from: Chemical Market Reporter January 10, 2000 700+ words
GENOME THERAPEUTICS Corporation and Wyeth-Ayerst Laboratories...osteoporosis using a gene associated with a unique high bone mass trait, a mirror Image of the disease. Genome Therapeutics could receive over $118 million in total payments...
Osteoporosis Deal Could Reap $118M For Genome Therapeutics.(Brief Article)
Newspaper article from: BioWorld Week December 27, 1999 700+ words
...osteoporosis process." Genome Therapeutics will use Its abilities...collaborating with Genome Therapeutics, said there is...add significant bone mass, reversing the...preventing fractures. Genome Therapeutics began collaborating...
Genome Therapeutics Announces Osteoporosis Genomics Alliance with Wyeth-Ayerst.
Press release article from: PR Newswire December 22, 1999 700+ words
...unique high bone mass trait, the...Ayerst will pay Genome Therapeutics an undisclosed...disorder. Genome Therapeutics' research...exhibiting a high bone mass trait identified...osteogenic agents. Genome Therapeutics Corp. (http...
For more facts and information, see all results

Source: HighBeam Research, Researchers Identify Gene Linked To High Bone Mass.(Brief Article)

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA